All items in the Healthy Skepticism Library
All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.
Page 192 of 206 pages ‹ First < 190 191 192 193 194 > Last ›
HSL3441
 Katz RA.
 Unhook me.
 J Am Acad Dermatol 1987 Nov;17:(5):
 
HSL3479
 Zuger A.
 Promoting Retrovir.
 N Engl J Med 1987 Oct 29;317:(18):1160
 
HSL3434
 Hardy AJ.
 Drug promotion.
 N Z Med J 1987 Oct 28;100:(834):667
 
HSL9598
 Revision of rules governing postmarketing reporting of adverse drug reactions 
 Federal Register 1987 Oct 13;52:37931-37936
 
HSL3526
 Bell KD.
 Drug advertising.
 Med J Aust 1987 Oct 5;147:(7):361
 
HSL3527
 Wing LM, Moulds RF, Shenfield GM, Day RO.
 Drug advertising [reply]
 Medical Journal of Australia 1987 Oct 5;147:361
 
HSL3423
 Finucane T.
 Drug company-sponsored symposia: pros and cons.
 Am J Med 1987 Oct;83:(4):811-2
 
HSL3522
 MaLAM letter follow up—Bayer
 MaLAM Newsletter 1987 Oct;
 
HSL3523
 Re: the promotion of lincomycin and clindamycin
 1987 Oct;
 
HSL3524
 Re: the promotion of trimethoprim/sulphamethoxazole/guaiphenesin/ammonium chloride
 1987 Oct;
 
HSL3525
 Advertisement of Rx drugs to health professionals
 1987 Oct;17
 
HSL9591
 Chappell SC.
 Among top 100 companies: 26 generic firms show aggregate 17% growth 
 Pharmacy Times 1987 Oct;53:63-64, 67-69
 
HSL3450
 Lexchin J.
 Drug promotion.
 N Z Med J 1987 Sep 23;100:(832):603
 
HSL3422
 de Groot AC, Nater JP, Herxheimer A.
 Minoxidil for male-pattern baldness.
 Lancet 1987 Sep 5;2:(8558):563
 
HSL3519
 The IFPMA code:  how it works and how it’s working
 International Federation of Pharmaceutical Manufacturers Associations 1987 Sep;
 
www.ifpma.rog/hhhs/welcome.htm
HSL3520
 Re: the promotion of flunarizine
 1987 Sep;
 
HSL9596
 McCarthy R.
 Repackager sees $3 billion market 
 American Druggist 1987 Sep;196:62, 64
 
HSL19897
 Chaplin S, Smith JM
 Data Sheet Warnings About Drug Safety in Pregnancy
 The Lancet 1987 Aug 29;330:(8557):516
 
http://www.lancet.com/journals/lancet/article/PIIS0140-6736%2887%2991832-0/fulltext
HSL9595
 Denysyk OS.
 Five-year prediction made for OTC products 
 Drug Topics 1987 Aug 17;131:64-65
 
HSL14687
 Pocock SJ, Hughes MD, Lee RJ.
 Statistical problems in the reporting of clinical trials. A survey of three medical journals.
 N Engl J Med. 1987 Aug 13;317:(7):426-32.
 
http://www.ncbi.nlm.nih.gov/pubmed/3614286
HSL3331
 Carter IE.
 Canadian Psychiatric Association guidelines in relating to the pharmaceutical industry.
 Can J Psychiatry 1987 Aug;32:(6):476-86
 
http://web.archive.org/web/20061019043917/http://www.cpa-apc.org/Publications/Position_Papers/Guideline.asp
HSL3417
 Buckley EG.
 Post-marketing surveillance of new drugs.
 J R Coll Gen Pract 1987 Aug;37:(301):337-8
 
HSL3512
 Crane VS, Jefferson KK, Morgan R.
 Rethinking pharmaceutical industry relationships.
 Am J Hosp Pharm 1987 Aug;44:(8):1884-6
 
HSL3515
 DOH proposes regulating of drug ads
 Drug Monitor 1987 Aug;2:(8):3-5
 
HSL3516
 Drug companies trying a facelift
 Drug Monitor 1987 Aug;2:(8):5-6
 
HSL3517
 IFPMA code: trivial requirements ignored by companies
 1987 Aug;1
 
HSL3518
 Organon and anabolic steroids
 WEMOS pharma group 1987 Aug;
 
HSL20513
 Eichorn P, Yankauer A
 Do authors check their references? A survey of accuracy of references in three public health journals.
 Am J Public Health 1987 Aug;77:(8):1011
 
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1647239/
HSL3429
 Graves J.
 Frequent-flyer programs for drug prescribing.
 N Engl J Med 1987 Jul 23;317:(4):252
 
HSL3437
 Hoppin ME.
 A university perspective on pharmaceutical and industry support of research.
 Am J Clin Nutr 1987 Jul;46:(1):
 
HSL3459
 Schweigert BS.
 University-industry partnership in research.
 Am J Clin Nutr 1987 Jul;46:(1):
 
HSL3473
 Weiss GB, Winslade WJ.
 Is post-marketing drug follow-up research or advertising?
 IRB 1987 Jul-Aug;9:(4):10-1
 
HSL3513
 Juergens JP.
 Advertising in the American Journal of Hospital Pharmacy.
 Am J Hosp Pharm 1987 Jul;44:(7):1647-51
 
HSL3514
 Zellmer WA.
 Prudent and sensible advertising policies.
 Am J Hosp Pharm 1987 Jul;44:(7):1651-3
 
HSL9569
 Alba Romero S
 Pharmaceutical industry of Valencia: economic-health context of pharmaceutical specialties 
 Boletin de la Sociedad Espanola de Historia de la Farmacia 1987 Jul-Dec;38:401-408
 
HSL9588
 Naude S.
 Competition Board report 
 South African Pharmaceutical Journal 1987 Jul;54:199
 
HSL9593
 Blauvelt BM, Erlanger DE.
 Marketing in the Asian arena: Part 1 
 Pharmaceutical Executive 1987 Jul;7:36, 40, 44, 46, 48
 
HSL9614
 George CF.
 Telling patients about their medicines.
 
Br Med J (Clin Res Ed) 1987 Jun 20;294:(6587):1566-7
 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=3113531
HSL2055
 Mansfield PR.
 Drug Advertising
 Med J Aust 1987 Jun 15;146:(12):660-661
 
HSL3442
 Ketelbey JW.
 Fenbufen trial in general practice.
 N Z Med J 1987 Jun 10;100:(825):361
 
HSL3449
 Lexchin J.
 Advertisement scrutiny.
 Lancet 1987 Jun 6;1:(8545):1323-4
 
HSL3416
 Bower AD, Burkett GL.
 Family physicians and generic drugs: a study of recognition, information sources, prescribing attitudes, and practices.
 J Fam Pract 1987 Jun;24:(6):612-6
 
HSL3436
 Hilton D.
 Promotion by the drug companies--should we accept their bribes?
 J R Coll Gen Pract 1987 Jun;37:(299):270
 
HSL3438
 Hull FM, Marshall T.
 Sources of information about new drugs and attitudes towards drug prescribing: an international study of differences between primary care physicians.
 Fam Pract 1987 Jun;4:(2):123-8
 
HSL3465
 Speller DC.
 The relationship between the Journal and the pharmaceutical industry.
 J Antimicrob Chemother 1987 Jun;19:(6):711-2
 
HSL3470
 Thomas J 3rd.
 National survey of hospital policies on pharmaceutical sales representatives' activities.
 Am J Hosp Pharm 1987 Jun;44:(6):1334-40
 
HSL3474
 Wells F.
 Promotion by the drug companies--the industry replies.
 J R Coll Gen Pract 1987 Jun;37:(299):270
 
HSL3509
 MaLAM letter follow up—Janssen
 MaLAM Newsletter 1987 Jun;1-2
 
HSL3510
 MaLAM letter follow up—Parke-Davis
 MaLAM Newsletter 1987 Jun;1
 
HSL3511
 MaLAM letter follow up—Sandoz
 MaLAM Newsletter 1987 Jun;
 
HSL9604
 Anderson LJ.
 Dealing with the clash beween HMO MDs and pharmacists 
 Pharmaceutical Executive 1987 Jun;7:54, 56, 58, 60
 
HSL9613
 Holland K.
 Beecham Group Plc 
 Pharmaceutical Journal 1987 May 30;238:675-678
 
HSL3428
 Goldfinger SE.
 A matter of influence.
 N Engl J Med 1987 May 28;316:(22):1408-9
 
HSL3460
 Seddon TD.
 Drug promotion.
 N Z Med J 1987 May 27;100:(824):327
 
HSL9608
 Enter the academic medical representative 
 Pharmaceutical Journal 1987 May 23;238:633
 
HSL3466
 Spitzer WO, Hutchinson T, Lane D.
 Postmarketing management of drug use: toward rational public policy.
 CMAJ 1987 May 15;136:(10):1022-4
 
HSL3448
 Lauritsen K, Havelund T, Laursen LS, Rask-Madsen J.
 Withholding unfavourable results in drug company sponsored clinical trials.
 Lancet 1987 May 9;1:(8541):1091
 
HSL3468
 Stross JK.
 Information sources and clinical decisions.
 J Gen Intern Med 1987 May-Jun;2:(3):155-9
 
HSL3507
 IFPMA code advisers
 International Federation of Pharmaceutical Manufacturers Associations 1987 May;(1):5
 
www.ifpma.rog/hhhs/welcome.htm
HSL3508
 Piroxicam
 1987 May;1-7
 
HSL9603
 Wertheimer AI.
 Prescription drug advertising to the consumer in the United States 
 International Pharmacy Journal 1987 May-Jul;1:106-107
 
HSL9606
 Concerning the case of: United States v. American Pharmaceutical Association and Michigan State Pharmaceutical Association, Civil No. G75-558 CA5, W.D. Michigan 
 Journal Michigan Pharmacist 1987 May;25:32-33
 
HSL3427
 Godden JO.
 Monitoring drug advertisements.
 Lancet 1987 Apr 25;1:(8539):980
 
HSL3435
 Hay DR.
 Drug promotion.
 N Z Med J 1987 Apr 8;100:(821):223
 
HSL3454
 Marks I, Mathews A.
 Treatment for panic.
 Lancet 1987 Apr 4;1:(8536):805
 
HSL9602
 Madhavan S, Schondelmeyer SW.
 Taking it over the counter: Part 1 
 Pharmaceutical Executive 1987 Apr;7:78, 80, 82
 
HSL9612
 McCarthy R.
 Tremors hit the drug chains 
 American Druggist 1987 Apr;195:34, 37-38, 40
 
HSL9587
 Final report on branch resolutions 
 Pharmaceutical Journal 1987 Mar 28;238:415
 
HSL9619
 Griffin JP, Sharp JR.
 Original pack dispensing.
 
Br Med J (Clin Res Ed) 1987 Mar 21;294:(6574):724-5
 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=3105709
HSL3447
 Laurence DR.
 The academic clinical pharmacologist and the Royal College of Physicians Report on the relationship between physicians and the pharmaceutical industry.
 Br J Clin Pharmacol 1987 Mar;23:(3):253-5
 
HSL3461
 Shelley JH.
 Relationships between physicians and the pharmaceutical industry: London Royal College of Physicians 1986.
 Br J Clin Pharmacol 1987 Mar;23:(3):257-8
 
HSL3506
 Perri M, Nelson AA Jr.
 An exploratory analysis of consumer recognition of direct-to-consumer advertising of prescription medications.
 J Health Care Mark 1987 Mar;7:(1):9-17
 
HSL9601
 Phillips JH.
 Dispensing with the RPh's services 
 American Druggist 1987 Mar;195:46-48
 
HSL9607
 Jacknowitz AI.
 Expiration dating and storage of drugs 
 US Pharmacist 1987 Mar;12:36, 38, 40, 106
 
HSL3504
 Dyer C.
 The penalties of issuing misleading advertisements.
 Br Med J (Clin Res Ed) 1987 Feb 14;294:(6569):426-7
 
HSL3505
 Editor .
 The penalties of issuing misleading advertisements [Editor's response]
 British Medical Journal 1987 Feb 14;294:427
 
HSL3481
 Double standards—some improvements
 HAI News 1987 Feb;(33):1-2, 12
 
HSL3482
 MLAM letter follow up—Pfizer
 1987 Feb;2
 
HSL3483
 MLAM letter follow up—Scanpharm
 1987 Feb;2
 
HSL3502
 Re: the promotion of co-dergocrine
 1987 Feb;
 
HSL3503
 Re: the promotion of loperamide
 1987 Feb;
 
HSL9600
 Perri M.
 Direct approach 
 Pharmaceutical Executive 1987 Feb;7:35, 38, 40, 42
 
HSL9617
 PMA surveys MDs on sampling 
 American Druggist 1987 Feb;195:120
 
HSL20238
 Leippe, MR, Elkin RA
 When Motives Clash: Issue Involvement and Response Involvement as Determinants of Persuasion 
 Journal of Personality and Social Psychology 1987 Feb;52:(2):269-278
 
http://psycnet.apa.org/index.cfm?fa=buy.optionToBuy&id=1987-15552-001
HSL3413
 Pharmaceutical funds for clinical research: a mixed blessing.
 Lancet. 1987 Jan 31;1:(8527):257-8
 
HSL3476
 Wilmshurst P.
 An investigation by the ABPI (Association of the British Pharmaceutical Industry)
 Lancet. 1987 Jan 10;1:(8524):104
 
HSL19894
 Herxheimer A, Collier J
 Medicine and the Law: Roussel Convicted of Misleading Promotion
 The Lancet 1987 Jan 10;113-114:
 
http://www.nelm.nhs.uk/en/NeLM-Area/Evidence/Medicines-Management/References/1987---January/01/Roussel-convicted-of-misleading-promotion/
HSL20504
 Herxheimer A
 Basic information that prescribers are not getting about drugs
 The Lancet 1987 Jan 3;329:(8523):31-33
 
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2887%2990713-6/fulltext
HSL3480
 Hoechst a cause of illness?  The pharmabusiness in the Third World
 1987 Jan;
 
HSL9610
 Maddock PH.
 Pharmacy in Colombia 
 International Pharmacy Journal 1987 Jan-Feb;1:
 
HSL9620
 Kaplan A, Becker R.
 Labeling or scientific exchange 
 Pharmaceutical Executive 1987 Jan;7:56-58
 
HSL13249
 Alba JW, Hutchinson JW.
 Dimensions of Consumer Expertise
 Journal of Consumer Research 1987 Jan;13:(4):411-454
 
http://www.journals.uchicago.edu/doi/abs/10.1086/209080
HSL2311
 Blondeel L, Cannoodt L, DeMeyeere M, Proesmans H
 Prescription behaviour of 358 Flemish general practitioners.
 1987
 
HSL3411
 Conviction for breach of Medicines Act in drug advertisement
 Lancet 1987;1:57
 
HSL3412
 Paediatricians get their skates on
 Lancet 1987;2:735
 
HSL3414
 Roussel appeal against advertisement decision
 Lancet 1987;1:233
 
HSL3415
 Bennett JC.
 The reply
 American Journal of Medicine 1987;83:812
 
HSL3418
 Burley D, Parr G.
 Role of the pharmaceutical industry in major clinical trials
 Lancet 1987;2:1464-1465
 
HSL3419
 Chotiner G.
 Response
 Journal of the American Academy of Dermatology 1987;17:866
 
HSL3420
 Collier J, Herxheimer A.
 Roussel convicted of misleading promotion
 Lancet 1987;1:113-114
 
Page 192 of 206 pages ‹ First < 190 191 192 193 194 > Last ›
 








 


